Product Development Partners
IPM employs a “virtual” product development model to maintain flexibility, compress development timelines for its internal pipeline of products and decrease overall costs.
Collaboration with external contract research organizations and academic laboratories is key to this undertaking.
The work done by these partners, many of whom are listed below, is managed by the product development professionals and scientists on IPM’s team.
The result is a product development operation that can make the most efficient use of resources, readily adapt to shifting priorities, and collaborate with other leading organizations to advance microbicide research and pipeline development.
|QPharma; Omnichem; Trelyst; Queens University-Belfast; Oak Crest Institute of Science; Magee-Womens Research Institute; Promed; Regis Technologies, Inc.||Manufacturing, product formulation and process development|
|Envigo CRS Ltd.; ABL Inc.; Tandem Labs; Institute for Tropical Medicine; Pyxant Labs; NAMSA||Preclinical evaluation and bioanalytical support|
|Imperial College London||Virology|
|Catalent; Parexal; IsoSciences LLC; Pharmaceutical Research Association||Analytical support|
|Partners Group; Almac; Fisher Clinical Services; Fisher Bioservices; Catalent; Clinical Systems Inc.; The Coghlan Group, Inc.||Clinical supply logistics|
|CONRAD; Population Council; CHAARM; Advanced Biosciences Laboratory||Scientific collaborations and support|